Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion
HOUSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, […]
United Lithium Appoints Anoop Prihar as Vice President Corporate Development, and Commences Scandinavian Marketing Campaign
VANCOUVER, British Columbia, Jan. 29, 2024 (GLOBE NEWSWIRE) — United Lithium Corp. (“United” or the “Company”) (CSE: ULTH; OTC: ULTHF; […]
Cartier Silver Announces $2 Million Financing
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. […]
Lantronix Wins Smart Buildings Innovation Award for POE++ Switch From IoT Evolution World
IRVINE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for […]
GRIID to Begin Trading on Nasdaq Global Market Under Ticker “GRDI”
CINCINNATI, Jan. 29, 2024 (GLOBE NEWSWIRE) — GRIID Infrastructure Inc. (“GRIID” or the “Company”) (NASDAQ: GRDI) (NEO: GRDI), an American […]
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the […]
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
Results from two positive Phase 3 studies point to Tonmya’s (TNX-102 SL) potential as a new first-line medicine for chronic […]
TSX News -
Bitfarms to Ring Nasdaq Closing Bell on January 30th
TORONTO, Ontario and BROSSARD, Québec, Jan. 29, 2024 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF // TSX: BITF), a global […]
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
BAUDETTE, Minn., Jan. 29, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that […]
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary […]
